| Literature DB >> 32232193 |
Xiaosa Chi1, Renliang Zhao2, Haitao Pei2, Ang Xing1, Song Hu1, Jingjiao Chen1, Yongjun Mao1, Xueping Zheng1.
Abstract
Diffusion-weighted imaging (DWI) MRI is very sensitive for detecting small embolic brain infarctions. Stroke as the first manifestation of cancer is extremely rare. We performed a retrospective study to identify the clinical and DWI features of patients with acute ischemic stroke as the first manifestation of occult cancer. A total of five patients in our hospital from January 2017 to May 2019 were analyzed. We also reviewed the literature and seven case series (16 patients) were included. Most of these patients were aged in their sixties and lung cancer was the most common type of occult cancer. Patients showed various presentations of ischemic stroke. All of the patients showed small multiple lesions on DWI that involved mostly the anterior or both anterior and posterior territories. The lesions were mostly in both the supratentorium and infratentorium, with the mechanisms of embolic and watershed infarcts. These features were useful for identifying the causes of embolic stroke. Therefore, patients with small bilateral embolic stroke, especially those involved in multiple vascular territories, should be examined for concealed malignancy.Entities:
Keywords: cancer; diffusion‐weighted imaging; embolic stroke; first manifestation
Year: 2020 PMID: 32232193 PMCID: PMC7099753 DOI: 10.1002/agm2.12105
Source DB: PubMed Journal: Aging Med (Milton) ISSN: 2475-0360
Basic clinical characteristics of the patients
| N | Sex | Age (years) | Symptom at onset | Cancer origin | Tumor pathology | Tumor stage | Vascular risk factors | Coagulation profile | D‐dimer level | TEE/TTE finding | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| This study | 1 | M | 75 | Dysarthria | Lung cancer | NA | NA | Hyperlipidemia | Normal | ↑ | Normal |
| 2 | F | 79 | Psychiatric abnormal | Lung cancer | NA | NA | Alcohol | Normal | ↑ | Normal | |
| 3 | F | 68 | Dizziness and dysarthria | Lung cancer | NA | NA | Hypertension | Normal | Normal | Normal | |
| 4 | M | 60 | Hemiparesis, numbness | Lung cancer | Squamous cell | II | Smoking | Normal | ↑ | Normal | |
| 5 | M | 68 | Dizziness | Lung cancer | Adenocarcinoma | IV | No | AT III ↓61% (80%‐140%) | Normal | Normal | |
| Park et al | 6 | F | 67 | Dysarthria, hemiparesis | Ovarian carcinoma | NA | NA | No | Normal | Normal | Normal |
| 7 | F | 79 | Dysarthria, hemiparesis | Pancreatic cancer | NA | IV | Hypertension, diabetes | APTT↑ | ↑ | Normal | |
| Kwon et al | 8 | F | 58 | Unknown | Cholangioadenocarcinoma | Adenocarcinoma | Metastasis | NA | NA | ↑ | Normal |
| 9 | M | 67 | Unknown | Pancreatic cancer | Adenocarcinoma | NA | NA | NA | ↑ | Normal | |
| 10 | M | 62 | Unknown | Lung cancer | Adenocarcinoma | Metastasis | NA | NA | NA | Normal | |
| 11 | F | 73 | Unknown | Acute myeloid leukemia | NA | NA | NA | NA | ↑ | Normal | |
| 12 | F | 57 | Unknown | Pancreatic cancer | NA | Metastasis | NA | NA | NA | Normal | |
| 13 | M | 82 | Unknown | Lung cancer | Squamous cell | Metastasis | NA | NA | NA | Normal | |
| 14 | F | 70 | Unknown | Unknown | Adenocarcinoma | Metastasis | NA | NA | ↑ | Normal | |
| Bond et al | 15 | F | 36 | Headache, impairment | Ovarian cancer | NA | NA | No | Normal | Normal | Normal |
| Chen et al | 16 | M | 65 | Hemiplegia | Malignant monoclonal proliferative disease of B cell | B cell | NA | Hypertension | Normal | ↑ | Normal |
| 17 | M | 56 | Hemiplegia, paresthesia | Lung cancer | NA | NA | No | APTT↑ | ↑ | Normal | |
| 18 | M | 50 | Transient hemiplegia | Acute nonlymphocytic leukemia | NA | NA | No | FIB↓ | ↑ | Normal | |
| Costa et al | 19 | F | 74 | Aphasia, crossed paralysis | Lung cancer | Non‐small cell | NA | Hypertension, dyslipidemia | FIB↓ | ↑ | Normal |
| Kawasaki et al | 20 | F | 80 | Unsteadiness of gait | Gastric cancer | Adenocarcinoma | NA | NA | Normal | ↑ | Normal |
| Tsai et al | 21 | M | 46 | Diplopia, ophthalmoplegia | Colon cancer | Adenocarcinoma | NA | Diabetes, dyslipidemia | Normal | Normal | Normal |
Abbreviations: APTT, activated partial thromboplastin time; AT III, antithrombin III; NA, not available; TEE/TTE, transesophageal echocardiography/transthoracic echocardiography.
Diffusion‐weighted imaging features of the patients
| Patient | Lesion number | Lesion distribution | Size | Site | Circulation involved | Infarction type |
|---|---|---|---|---|---|---|
| 1 | Multiple | Bilateral | Small | Supratentorium | Anterior | Embolic |
| 2 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic |
| 3 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic and watershed |
| 4 | Multiple | Bilateral | Small | Supratentorium | Anterior and posterior | Embolic and watershed |
| 5 | Multiple | Bilateral | Small | Supratentorium and infratentorium | Anterior and posterior | Embolic and watershed |
| 6 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic and watershed |
| 7 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic and watershed |
| 8 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic and watershed |
| 9 | Multiple | Bilateral | Small and large | Supratentorium | Anterior and posterior | Embolic |
| 10 | Multiple | Bilateral | Small and large | Supratentorium | Anterior | Embolic |
| 11 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic and watershed |
| 12 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic |
| 13 | Multiple | Bilateral | Small and large | Supratentorium | Anterior and posterior | Embolic and watershed |
| 14 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic |
| 15 | Multiple | Bilateral | Small | Supratentorium and infratentorium | Anterior and posterior | Embolic |
| 16 | Multiple | Bilateral | Small and large | Supratentorium and infratentorium | Anterior and posterior | Embolic |
| 17 | Multiple | Bilateral | Small | Supratentorium | Anterior and posterior | Embolic |
| 18 | Multiple | Left | Large | Supratentorium | Anterior | Embolic |
| 19 | Multiple | Bilateral | Small | Supratentorium and infratentorium | Anterior and posterior | Embolic |
| 20 | Multiple | Bilateral | Small | Supratentorium | Anterior | Embolic |
| 21 | Multiple | Bilateral | Small | Supratentorium and infratentorium | Anterior and posterior | Embolic |
FIGURE 1Diffusion‐weighted imaging patterns of our five patients.